June 20, 2025
admin
What is the last grey market premium of Aakaar Medical Technologies IPO?
Listing Review: Will update on listing.
Subscription status of Aakaar Medical Technologies IPO
|
Aakar Medical IPO Price Rs. 72 Lot 1600 shares, Rs.27.00 Crore |
||||
| QIB | NII x | RII x | Total x | Applications |
| 0.33 | 0.59 | 0.30 | 0.37 | 249 |
| Subscription Review: Unimpressive flow of application till now. |
||||
Aakaar Medical Technologies IPO Allotment Link:
What is the business of Aakaar Medical Technologies?
Aakaar Medical Technologies Limited is a fast-growing aesthetic medical company at the forefront of cosmetic innovation. With a curated portfolio of advanced products and cutting-edge devices, Aakaar serves the needs of dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists across India.
Specializing in Beauty, Backed by Science
Aakaar offers a comprehensive range of both in-house and internationally sourced brands—manufactured in India and imported from global leaders in aesthetic technology including South Korea, Spain, Italy, and Austria.
Its products are trusted by medical professionals who use them in clinical procedures and retail them directly to end consumers for at-home skincare and haircare regimens.
Diverse Product Portfolio
Its offerings cover a full spectrum of cosmetic and aesthetic needs:
- Homecare & Professional Skincare Solutions
Serums, creams, and treatments tailored for individual and clinical use. - Injectables & Contouring Products
Designed for precision aesthetic enhancements. - Hair Care & Regrowth
Hair growth serums, anti-hair loss solutions, and nutraceutical tablets. - Medifacial Kits
Complete kits for rejuvenating, skin-brightening, and anti-aging treatments. - Advanced Medical Devices
- Urinary incontinence therapy devices
- Tattoo removal, pigmentation correction & skin rejuvenation systems
- Laser hair reduction machines
- Hair transplant equipment
Nationwide Reach & Expert Support
With a robust network of branches across India and a team of 90 trained sales and service professionals, Aakaar ensures timely support and seamless customer experience for thousands of aesthetic practitioners.
Operational Footprint
The company serves healthcare professionals in the following states:
Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Get more information about the company @
Aakaar Medical Technologies IPO Details
|
Sector: |
|
| IPO opens on | 20 June 2025 |
| IPO closes on | 24 June 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 3750400 Shares / Rs 27.00 Crore |
| * Fresh Issue | 3750400 Shares / Rs 27.00 Crore |
| * Offer for Sale – | – |
| Market Maker Portion | 188800 Shares |
| Net offer to Public | 3561600 Shares Rs.25.64 Crores |
| Face Value per share | Rs. 10 |
| Price Band | Rs. 68-72 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 1600 Shares |
| Listing will at | NSE SME |
| Category | Shares Offered | % of offer | Rs. In Cr. |
| Market Maker | 188,800 | 5.03% | |
| QIB | 1779,200 | 47.42% | |
| Anchor Investors | 1067,200 | 28.44% | |
| QIB (Ex. Anchor) |
712,000 | 18.98% | |
| NII (HNI | 536,000 | 14.29% | 3.86 |
| Retail | 1248,000 | 33.29% | 8.99 |
| Total Shares | 3752,000 | 100.00% | |
| RII portion will be oversubscribed by | 780 | forms | |
| Lot | Shares | Amount | |
| RII-Min | 1 | 1600 | 1,15,200 |
| RII-Max | 2 | 1600 | 1,15,200 |
| HNI-Min | 3 | 3200 | 2,30,400 |
Who are the Promoters of Aakaar Medical Technologies?
Dilip Ramesh Meswani and Bindi Dilip Meswani are the Promoters of the company
What are the Objects of Aakaar Medical Technologies IPO?
- Funding working capital requirements of the Company Rs. 20.35 Cr.
2. General corporate purposes
Aakaar Medical Technologies Timetable
Tentative timetable |
|
| IPO opens on | 20 June 2025 |
| IPO Closes on | 24 June 2025 |
| IPO Allotment on | 25 June 2025 |
| Refund Initiation | 26 June 2025 |
| Credit of Shares | 26 June 2025 |
| Listing on | 27 June 2025 |
|
Registered Office of the Company |
|
The Lead Manager of this IPO |
|
Who is the Registrar to IPO? |
Aakaar Medical Technologies IPO GMP grey market premium, review, Subscription, allotment, listing estimate
Aakaar Medical Technologies Financials
| Period Ended | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
| Assets | 51.85 | 34.01 | 23.23 |
| Revenue | 61.76 | 46.27 | 32.88 |
| Profit After Tax | 6.04 | 2.87 | 2.15 |
| EBITDA | 0 | 0 | 0 |
| Net Worth | 23.2 | 12.53 | 9.66 |
| Reserves and Surplus | 12.78 | 11.84 | 8.96 |
| Total Borrowing | 22.74 | 15.06 | 5.87 |
| Amount in Rs. Crore | |||
Performance Indicators
| KPI | Values |
| ROCE | 21.02% |
| Debt/Equity | 0.98 |
| RoNW | 33.81% |
| PAT Margin | 9.81 |
| Price to Book Value | 5.23 |
| EPS | Rs.5.79 |
| PE Ratio | 12.43 |
How Aakaar Medical Technologies IPO compares with the Peers?
There is no peer group listed company
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Aakaar Medical Technologies IPO Review by Paresh Gordhandas, CA & Research Analyst.
Aakaar Medical Technologies Limited is one of India’s fastest-growing players in the aesthetic and cosmetic medical space. Positioned at the intersection of innovation and wellness, Aakaar delivers a premium portfolio of advanced medical devices and aesthetic solutions to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists nationwide.
With a sharp focus on quality, safety, and results, Aakaar offers a well-curated mix of in-house innovations and globally recognized brands, sourced from industry leaders across South Korea, Spain, Italy, and Austria—as well as high-quality products manufactured right here in India.
Financial Highlights & IPO Insights
The company’s financial performance has shown impressive momentum. In FY 2024–25, net profit surged to Rs.6.04 crore, more than doubling from Rs.2.87 crore in FY 2023–24. While this significant increase demonstrates strong growth potential, the sharp jump in the bottom line warrants closer scrutiny for sustainability.
-
IPO Size: Rs.25.64 crore — modest in scale, offering manageable risk for new investors.
-
Retail Quota: Rs.8.99 crore — could be fully subscribed with just 780 retail applications.
-
HNI Allocation: Rs.3.86 crore — suggesting limited competition in this category.
-
Valuation: Shares are being offered at a P/E multiple of 12.43, based on the FY25 profits—reasonable, but tied to the company’s ability to maintain its earnings growth.
Currently, no notable premium has been observed in the grey market, indicating muted pre-listing sentiment.
Conclusion
Aakaar Medical Technologies stands at the cusp of opportunity in a fast-evolving industry. While the company’s product mix, international partnerships, and rapid profit growth are attractive, the sharp rise in earnings and lack of grey market enthusiasm suggest that potential investors should proceed with balanced optimism and due diligence.
+ from fundamental angle: May apply
+ from grey market angle: Not attractive
Quicklinks
